A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Clindamycin Palmitate (Cleocin Pediatric)

Lincosamide Antibacterial class · 7 generic manufacturers · 7 ANDAs filed at FDA.

First FDA approval1986-04-17
Generic availableYes · 7 mfrs
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$730,703 in CY2024 Part D spend7K claims · 6K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.139/unit
4 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.139
Across all dosage forms in distribution.
Highest NADAC
$0.139
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Clindamycin Palmitate used for?

Clindamycin Palmitate is a Lincosamide Antibacterial medication tracked in Medicare Part D.

Is there a generic for Clindamycin Palmitate?

Yes. 7 ANDAs filed at FDA, 7 generic manufacturers currently shipping.

How much does my plan pay for Clindamycin Palmitate?

Across 329 Part D plans, Clindamycin Palmitate averages $0.139/unit (NADAC). Lowest available: $0.139/unit. Highest in distribution: $0.139/unit.

Is Clindamycin Palmitate on the FDA shortage list?

Clindamycin Palmitate has been discontinued by its manufacturer(s).

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Lincosamide Antibacterial3 alternatives in D1
01
Clindamycin In 5 Percent Dextrose
Lincosamide Antibacterial
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Clindamycin In Percent Dextrose
Brand: Clindamycin in 5 percent Dextrose
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Clindamycin and Benzoyl Peroxide
Brand: Acanya
$0.432Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (7 approvals on file) · NADAC unit costs: CMS NADAC weekly file (4 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.